Fujitsu today announced the development of a safe and efficient AI agent platform to accelerate operational efficiency and ensure stable medical services in the Japanese medical sector. The new platform includes Orchestrator AI Agent, a centralized system that supports collaboration and coordination of multiple professional medical-specific agents developed by Fujitsu and other partners. The initiative aims to contribute to the rapid implementation of world-leading healthcare operation practices, thereby fostering business transformation and improving sustainability in the Japanese healthcare industry. The development of this platform was supported by Nvidia, a global leader in accelerated computing and fundamental AI agent technology.
In 2025, Fujitsu will work with advanced medical institutions and partners around the world to verify the effectiveness of newly developed healthcare orchestrator AI agents and accelerate the commercialization of its platform by developing AI agents focused on specific industries.
Under the Fujitsu UVance business model, which aims to address social challenges, Fujii continues to transform medical care and drug discovery through data and AI, creating a society where individual treatment opportunities can be used by anyone, and advances individual happiness.
